초록 ▼

In the liquid crystal display10,consisting of a first substrate (12) and a second substrate (14) facing each other, either or both of the first substrate (12) and the second substrate (14) is/are disposed in a non-display region, the spacers18consisting of a photosensitive resin regulating the cell

In the liquid crystal display10,consisting of a first substrate (12) and a second substrate (14) facing each other, either or both of the first substrate (12) and the second substrate (14) is/are disposed in a non-display region, the spacers18consisting of a photosensitive resin regulating the cell gaps16between both substrates12and14,and liquid crystal20sandwiched between the first substrate (12) and the second substrate (14), either a dynamic hardness value or a plastic deformation hardness value is within a fixed range.

대표청구항 ▼

In the liquid crystal display10,consisting of a first substrate (12) and a second substrate (14) facing each other, either or both of the first substrate (12) and the second substrate (14) is/are disposed in a non-display region, the spacers18consisting of a photosensitive resin regulating the cell

In the liquid crystal display10,consisting of a first substrate (12) and a second substrate (14) facing each other, either or both of the first substrate (12) and the second substrate (14) is/are disposed in a non-display region, the spacers18consisting of a photosensitive resin regulating the cell gaps16between both substrates12and14,and liquid crystal20sandwiched between the first substrate (12) and the second substrate (14), either a dynamic hardness value or a plastic deformation hardness value is within a fixed range. CO2R5; CON(R5)2; wherein R 10is H; or C1-C6alkyl; wherein R 11is H; COR5; COR12; SO2R5; SO2R12; and wherein R 12is phenoxy; phenyl, pyridyl; thiophenyl; or naphthyl; wherein the phenoxy, phenyl, pyridyl, thiophenyl or naphthyl is substituted with H, F, Cl, Br, I, CF3, C1-C4alkyl, C1-C4alkoxy, C1-C4alkylthio, NO2, phenyl, pyridyl or thiophenyl; or a pharmaceutically acceptable salt thereof. 2. An (+) enantiomer of the compound of claim 1.3. An (−) enantiomer of the compound of claim 1.4. A compound of claim 1, wherein R 1is H; wherein L is  and wherein W is 5. A compound of claim 4, wherein Ar is selected from: wherein each of R 2, R3and R4is independently H; F, Cl, Br or I; CN; CF3; NO2; OH; C1-C4alkoxy; C1-C4hydroxyalkyl; C1-C4monohaloalkyl; C1-C4polyhaloalkyl; N(R5)2; or N(SO2R5)2; wherein X is a single bond; wherein L is wherein R 7is H; CH2OH; or CH2OR5; and wherein W is 6. A compound of claim 5, wherein K is —CH2—NR10—CO—(CH2)j—.7. The compound of claim 6, wherein the compound has the structure:8. The compound of claim 6, wherein the compound has the structure:9. The compound of claim 6, wherein the compound has the structure:10. The compound of claim 6, wherein the compound has the structure:11. The compound of claim 6, wherein the compound has the structure:12. The compound of claim 6, wherein the compound has the structure:13. The compound of claim 6, wherein the compound has the structure:14. A method of modifying feeding behavior of a subject in need thereof which comprises administering to the subject an effective amount of the compound of claim 1 to decrease the consumption of food by the subject so as to thereby modify feeding behavior of the subject.15. A method of treating feeding disorder in a subject in need thereof which comprises administering to the subject an effective amount of the compound of claim 1 to decrease the consumption of food by the subject.16. The method of claim 15, wherein the feeding disorder is bulimia, obesity or bulimia nervosa.17. The method of claim 14 or15, wherein the compound is administered in combination with food.18. The method of claim 14 or15, wherein the subject is a vertebrate, a mammal, a human or a canine.19. The method of claim 14 or15 wherein the compound has the structure:20. The method of claim 14 or15, wherein the compound has the structure:21. The method of claim 14 or15, wherein the compound has the structure:22. The method of claim 14, or15, wherein the compound has the structure:23. The method of claim 14 or15, wherein the compound has the structure:24. The method of claim 14 or15, wherein the compound has the structure:25. The method of claim 14 or15, wherein the compound has the structure: